These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinicopathologic features and Epstein-Barr virus infection status of Burkitt's lymphoma in Guangzhou district. Huang YH; Wu QL; Zong YS; Feng YF; Liang JZ; Hou JH; Shao Q; Fu J Ai Zheng; 2009 Aug; 28(8):805-12. PubMed ID: 19664325 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time. Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey. Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271 [TBL] [Abstract][Full Text] [Related]
6. Sporadic Burkitt lymphoma in southern China: 12 years' experience in a single institution in Guangzhou. Ye Z; Xiao Y; Shi H; Ke Z; Liu Y; Liang Y; Han A J Clin Pathol; 2011 Dec; 64(12):1132-5. PubMed ID: 21653657 [TBL] [Abstract][Full Text] [Related]
7. Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma. El-Mallawany NK; Day N; Ayello J; Van de Ven C; Conlon K; Fermin D; Basrur V; Elenitoba-Johnson K; Lim M; Cairo MS Eur J Cancer; 2015 Jan; 51(1):92-100. PubMed ID: 25466511 [TBL] [Abstract][Full Text] [Related]
8. Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomas. Spina D; Leoncini L; Megha T; Gallorini M; Disanto A; Tosi P; Abinya O; Nyong'O A; Pileri S; Kraft R; Laissue JA; Cottier H J Pathol; 1997 Jun; 182(2):145-50. PubMed ID: 9274523 [TBL] [Abstract][Full Text] [Related]
9. EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations. Courville EL; Yohe S; Chou D; Nardi V; Lazaryan A; Thakral B; Nelson AC; Ferry JA; Sohani AR Mod Pathol; 2016 Oct; 29(10):1200-11. PubMed ID: 27443517 [TBL] [Abstract][Full Text] [Related]
10. Burkitt's lymphoma in Brazil: strong association with Epstein-Barr virus. Bacchi MM; Bacchi CE; Alvarenga M; Miranda R; Chen YY; Weiss LM Mod Pathol; 1996 Jan; 9(1):63-7. PubMed ID: 8821959 [TBL] [Abstract][Full Text] [Related]
11. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection. Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934 [TBL] [Abstract][Full Text] [Related]
12. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases. Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710 [TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Bellan C; Lazzi S; Hummel M; Palummo N; de Santi M; Amato T; Nyagol J; Sabattini E; Lazure T; Pileri SA; Raphael M; Stein H; Tosi P; Leoncini L Blood; 2005 Aug; 106(3):1031-6. PubMed ID: 15840698 [TBL] [Abstract][Full Text] [Related]
14. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement. Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997 [TBL] [Abstract][Full Text] [Related]
15. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases. Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262 [TBL] [Abstract][Full Text] [Related]
16. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival. Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103 [TBL] [Abstract][Full Text] [Related]
17. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial. de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426 [TBL] [Abstract][Full Text] [Related]
18. Burkitt lymphoma in Iraqi children: A distinctive form of sporadic disease with high incidence of EBV Uccini S; Al-Jadiry MF; Cippitelli C; Talerico C; Scarpino S; Al-Darraji AF; Al-Badri SAF; Alsaadawi AR; Al-Hadad SA; Ruco L Pediatr Blood Cancer; 2018 Dec; 65(12):e27399. PubMed ID: 30207048 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders. Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S; Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047 [TBL] [Abstract][Full Text] [Related]
20. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]